GlassScriptPhysician profile
Peter Azarcon Reyes
NPI 1508898370
$11,137.29
in general payments reported to CMS, 2019-2025
48 companies · $1,568 in 2025
The $1,568 reported for 2025 was more than what 79% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,972 · 2020: $546 · 2021: $1,095 · 2022: $1,906 · 2023: $1,987 · 2024: $2,063 · 2025: $1,568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,618.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,162.40 | 2021-2025 | Jot Dx, Aveir, Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $1,423.14 | 2019-2025 | |
| Pfizer INC. | $775.09 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $756.36 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $608.18 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $584.72 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $422.21 | 2019-2024 | Brilinta, Farxiga, Airsupra |
| Boston Scientific Corporation | $381.91 | 2019-2025 | Watchman Flx |
| Philips North America LLC | $315.98 | 2020-2025 | Ambulatory Monitoring & Diagnostics Undivided, (5091) Amb Mon & Diag Und |
| Merck Sharp & Dohme LLC | $291.35 | 2021-2025 | Verquvo |
| Sanofi-Aventis U.S. LLC | $288.91 | 2019-2024 | |
| Amgen INC. | $262.03 | 2021-2025 | Repatha, Repatha |
| Daiichi Sankyo INC. | $237.86 | 2023-2024 | Injectafer |
| Amarin Pharma, INC. | $227.94 | 2019-2022 | |
| Novo Nordisk INC | $210.31 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $186.59 | 2019-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $176.38 | 2024 | Arcalyst |
| Regeneron Healthcare Solutions, INC. | $173.85 | 2019-2023 | Evkeeza |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.59 | 2019-2025 | Lifevest |
| Baxter Healthcare | $149.66 | 2019-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Edwards Lifesciences Corporation | $133.00 | 2019-2022 | |
| Scpharmaceuticals INC. | $117.04 | 2023-2025 | |
| Atricure, INC. | $115.53 | 2019-2023 | |
| Kestra Medical Technology Services, INC. | $112.95 | 2023-2024 | Assure Wcd |
| Medtronic, INC. | $112.37 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $106.11 | 2021-2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $65.72 | 2021-2024 | |
| Lilly USA, LLC | $64.55 | 2025 | Mounjaro, Zepbound |
| Portola Pharmaceuticals, LLC | $62.20 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $43.94 | 2022-2024 | Givlaari |
| Bridgebio Pharma, INC. | $38.04 | 2025 | Attruby |
| Shield Therapeutics INC | $29.63 | 2023 | Accrufer |
| Lexicon Pharmaceuticals, INC. | $27.11 | 2024 | |
| Genzyme Corporation | $26.27 | 2022 | |
| Exact Sciences Corporation | $26.13 | 2025 | The Cologuard Plus Collection Kit |
| Esperion Therapeutics, INC. | $25.76 | 2025 | Nexletol |
| Z-Medica, LLC | $25.57 | 2019 | |
| Ucb, INC. | $24.96 | 2025 | Nayzilam |
| Dexcom, INC. | $24.81 | 2024 | Dexcom G6 Transmitter |
| Biotronik INC. | $24.64 | 2021 | |
| Cvrx, INC. | $24.05 | 2024 | Barostim Neo System |
| Astellas Pharma US INC | $23.88 | 2019 | |
| Sumitomo Pharma America, INC. | $21.16 | 2025 | Gemtesa |
| Braemar Manufacturing, LLC | $18.72 | 2019 | |
| Abbvie INC. | $16.51 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.74 | 2025 | |
| Irhythm Technologies, INC. | $12.22 | 2019 | |
| Itamar Medical INC | $11.22 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Reyes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.